Frederick CREST is proud to announce Dr. Mohan C Vemuri as an addition to the Governing Board.
Dr. Vemuri is the Director of Research and Development for Cell Biology at Thermo Fisher Scientific. In this capacity, he leads R&D activities in stem cell product development in the areas of human iPSC, adult stem cells, immune cells and cell lineage‐ specific differentiation in GMP environment for research use and subsequently for use in cell therapy with regulatory compliance.
Prior to this role, Dr Vemuri served on the faculty at Children’s Hospital of Philadelphia where his research efforts focused on developing improved methods for fetal transplantation of engineered hematopoietic stem cells for blood and bone marrow transplantation.
Dr. Vemuri previously served on the faculty at Thomas Jefferson Medical School, where he developed cell screening assay systems for Parkinson’s disease drug discovery.
Dr. Vemuri collaborates with researchers in academia and industry, striving towards the successful utilization of stem cells in regenerative cell therapies. -He holds a Ph.D in Cell Biology from Sri Venkateswara University in India and performed his postdoctoral work at the National Institutes of Health.
He has also authored over 50 publications and has edited or co‐edited several stem-cell-focused books, including Stem Cell Assays, Regulatory Networks in Stem Cells, MSC assays and applications, MSCs and Cell Therapy, Neural Development and Stem Cells and most recently, Pluripotent Stem Cell Assays by Springer Press.
At Frederick CREST, we’re incredibly excited to add Dr. Vemuri’s insight and expertise to the Governing Board, and we look forward to working with him as we continue to promote the development of science and technology in Frederick.